New drug combo tested to stop second strokes
NCT ID NCT07174414
Summary
This study aims to see if adding the drug cilostazol to a standard blood thinner (aspirin or clopidogrel) is better at preventing another stroke or heart attack in people who recently had a stroke or mini-stroke. It will enroll 2000 participants who have had a stroke or TIA within the last 6 months and are already on one of the standard medications. The main goal is to see if this combination reduces the risk of major heart and blood vessel problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.